Adaptive Biotechnologies hosted "Utilizing immunosequencing in cancer research and immunotherapy," a sponsored symposia during the 2021 SITC Annual Meeting. Available here is the recording from the symposia.Program SummaryAdaptive Biotechnologies’ immunoSEQ® Technology is an end-to-end immunosequencing solution capable of profiling millions of B- and T-cell receptors at high throughput and providing a quantitative view into the immune repertoire. This program was presented by Katie Boland, DVM, PhD ("The principles behind the immunoSEQ Technology"), with guest speakers Kellie N. Smith, PhD ("Using immunoSEQ in the solid tumor setting") and Dr. Theodore Scott Nowicki, MD, PhD ("Addressing epigenetic suppression and optimizing therapies with immunosequencing").Sponsored Symposia content and views expressed therein are those of the sponsoring organization and not of SITC.
Adaptive Biotechnologies – Sponsored Symposia00:44:17